Publication dates

Rna Interference Industry, October 2014 Market Research & Statistics

You might be interested in: cotton, vaccine, drug

1-10 of 90 reports for Rna Interference

Antibody market trends in the US

  • Ebola & Marburg Virus Vaccine Elisa Kits, Recombinant Proteins, ...
  • January 2014
    6 pages
  • Antibody  

    Vaccine  

  • United States  

View report >

Biotechnology Industry - Analyst Report, 2014

  • Bb Biotech Ag
  • January 2014
    8 pages
  • Biotechnology  

    Biotech  

  • United States  

View report >

Cotton Industry in Argentina

  • Cartagena de Indias, Colombia
  • January 2013
    27 pages
  • Cotton  

    Textile  

  • Argentina  

    South America  

View report >

Healthcare Demand Forecast in the US

  • Industry Fragmentation Remains High, with Operators Looking to G...
  • April 2014
    20 pages
  • Healthcare  

    Medical Facilit...  

  • United States  

    North America  

View report >

The future of the Poultry Industry in India

  • January 2013
    41 pages
  • Poultry  

  • India  

View report >

Medicine Markets in the US

  • Full Color
  • January 2013
    78 pages
  • Medicine  

  • United States  

View report >

Cotton Industry in the US and India - Forecast

  • Reliance Forays into Nonwoven Manufacture
  • January 2014
    122 pages
  • Cotton  

    Textile  

    Nonwovens  

  • United States  

    India  

View report >

Hay Industry in the US

  • Draft Environmental Assessment
  • May 2014
    106 pages
  • Hay  

  • United States  

    North America  

View report >

Thermo Fisher Scientific Incorporated - Annual Report, 2013

  • The World Leader in Serving Science
  • January 2013
    134 pages
  • United States  

View report >

Fruit And Vegetable Industry in Africa

  • African Traditional Herbal Research Clinic
  • January 2013
    92 pages
  • Fruit And Veget...  

    Banana  

  • Africa  

View report >
6 reports for Rna Interference

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 6 650)

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.